XML 68 R56.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Aug. 31, 2021
Nov. 30, 2018
May 31, 2015
Equity          
Fair value of warrant $ 8,043 $ 8,043      
Share repurchase program authorized amount     $ 100,000    
Treasury stock repurchased 17,480 17,480      
Amount available for share repurchases under the program $ 82,520 $ 82,520      
Number of shares repurchased (in shares) 859,040 859,040      
Total cost of shares received $ 17,480 $ 17,480      
2014 Stock Incentive Plan          
Equity          
Shares of common stock authorized for issuance (in shares)         2,700,000
Increase in number of authorized shares on the first day of each fiscal year, as a percentage of outstanding common stock (as a percent)   4.00%      
Shares of common stock remaining available for future grant (in shares) 1,166,639 1,166,639      
Vesting period (in years)   4 years      
Contractual life (in years)   10 years      
Third Amendment to the Nucynta Commercialization Agreement          
Equity          
Number of shares that can be purchased       1,041,667  
Exercise price of warrant (in dollars per share)       $ 19.20  
Maximum | 2014 Stock Incentive Plan          
Equity          
Period following termination date vested options are exercisable (in months)   3 months